We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Apyx Medical
APYX
$171M
| $387K | ﹤0.01% |
40,062
-1,905
| -5% | -$19.1K |
|
2602
KALA BIO
KALA
$14.5M
| $387K | ﹤0.01% |
23
+1
| +5% | +$19.5K |
|
2603
Shattuck Labs
STTK
$694M
| $387K | ﹤0.01% |
13,245
+857
| +7% | +$36K |
|
2604
HF Foods Group
HFFG
$83.4M
| $386K | ﹤0.01% |
53,410
-1,415
| -3% | -$10.9K |
|
2605
Utah Medical Products
UTMD
$225M
| $386K | ﹤0.01% |
4,460
-150
| -3% | -$13.2K |
|
2606
National Bankshares
NKSH
$268M
| $385K | ﹤0.01% |
10,831
-375
| -3% | -$12.7K |
|
2607
Ooma
OOMA
$604M
| $384K | ﹤0.01% |
24,212
-1,470
| -6% | -$22.9K |
|
2608
Quad
QUAD
$525M
| $384K | ﹤0.01% |
108,906
+51,927
| +91% | +$247K |
|
|
PRTK
2609
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $383K | ﹤0.01% |
54,227
-1,840
| -3% | -$13.3K |
|
|
FCBP
2610
DELISTED
First Choice Bancorp Common Stock
FCBP
| $383K | ﹤0.01% |
15,760
-520
| -3% | -$11K |
|
2611
XBiotech
XBIT
$69.2M
| $382K | ﹤0.01% |
22,229
-680
| -3% | -$12.7K |
|
|
XONE
2612
DELISTED
The ExOne Company
XONE
| $382K | ﹤0.01% |
+12,172
| New | +$383K |
|
2613
ACNB Corp
ACNB
$655M
| $381K | ﹤0.01% |
13,019
-250
| -2% | -$7K |
|
2614
C4 Therapeutics
CCCC
$412M
| $380K | ﹤0.01% |
10,281
+1,689
| +20% | +$67.2K |
|
|
PLYM
2615
DELISTED
Plymouth Industrial REIT
PLYM
| $380K | ﹤0.01% |
22,581
+846
| +4% | +$13.2K |
|
2616
Escalade
ESCA
$311M
| $379K | ﹤0.01% |
18,126
-710
| -4% | -$15.3K |
|
|
CSTR
2617
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $378K | ﹤0.01% |
21,904
-830
| -4% | -$13.3K |
|
|
BVH
2618
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $377K | ﹤0.01% |
20,357
-760
| -4% | -$11.9K |
|
2619
Distribution Solutions Group
DSGR
$1.61B
| $374K | ﹤0.01% |
14,440
-420
| -3% | -$10.9K |
|
2620
Viemed Healthcare
VMD
$371M
| $374K | ﹤0.01% |
36,943
-1,780
| -5% | -$16.8K |
|
|
EAR
2621
DELISTED
Eargo, Inc. Common Stock
EAR
| $374K | ﹤0.01% |
375
+21
| +6% | +$24K |
|
2622
Noodles & Co
NDLS
$107M
| $372K | ﹤0.01% |
4,491
-185
| -4% | -$14.4K |
|
2623
Autoliv
ALV
$9B
| $369K | ﹤0.01% |
3,977
-134
| -3% | -$12.4K |
|
2624
Cytosorbents Corp
CTSO
$22.6M
| $369K | ﹤0.01% |
42,558
-2,365
| -5% | -$22.5K |
|
2625
Hurco Companies Inc
HURC
$143M
| $369K | ﹤0.01% |
10,463
-380
| -4% | -$12.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.